Tae-Yong Kim

9PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 14, 2025
Longitudinal trajectory of menopausal symptoms in premenopausal women throughout adjuvant chemotherapy: a two-stage analytical approach.

Saim Jung, Jaehyun Kim, Sun Hyung Lee

|Jul 13, 2024
Differences in severity of chemotherapy-induced nausea and vomiting between neoadjuvant and adjuvant chemotherapy in patients with breast cancer: analysis of data from two prospective observational studies.

Kyung-Lak Son, Joon Sung Shin, Sun Hyung Lee

|Jul 25, 2023
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma.

Samuel J Klempner, Keun-Wook Lee, Kohei Shitara

|Feb 08, 2023
Recent Progress in Immunotherapy for Gastric Cancer.

Jeesun Yoon, Tae-Yong Kim, Do-Youn Oh

|Feb 08, 2022
Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer.

Kyung-Lak Son, Dooyoung Jung, Kwang-Min Lee

Pageof 2